SKI Market

Indian Indices

Sensex

85,408.70 -116.14
( -0.14%)

Global Indices

Nasdaq

48,752.17 288.75
(0.60%)

Dow Jones

6,952.35 21.56
(0.31%)

Hang Seng

50,375.92 -36.95
(-0.07%)

Nikkei 225

9,870.68 -18.54
(-0.19%)

Forex

USD-INR

89.57 -0.04
(-0.05%)

EUR-INR

105.52 0.34
(0.32%)

GBP-INR

120.86 0.52
(0.43%)

JPY-INR

0.57 0.00
(0.60%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Welcure Drugs & Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524661

INE331C01025

1.0860857

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

1.61

55.62

EPS(TTM)

Face Value()

Div & Yield %

0.28

Back

sri rpp infra projects ltd

Concord Biotech standalone net profit declines 36.27% in the September 2025 quarter

Nov 15,2025

Net profit of Concord Biotech declined 36.27% to Rs 62.90 crore in the quarter ended September 2025 as against Rs 98.70 crore during the previous quarter ended September 2024. Sales declined 20.35% to Rs 247.06 crore in the quarter ended September 2025 as against Rs 310.18 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	247.06	310.18	-20
OPM %	36.65	44.06	-
PBDT	103.92	146.60	-29
PBT	85.53	133.29	-36
NP	62.90	98.70	-36

85,408.70 -116.14 ( -0.14%)

48,752.17 288.75 (0.60%)

6,952.35 21.56 (0.31%)

50,375.92 -36.95 (-0.07%)

9,870.68 -18.54 (-0.19%)

89.57 -0.04 (-0.05%)

105.52 0.34 (0.32%)

120.86 0.52 (0.43%)

0.57 0.00 (0.60%)